ResearcherJiangsu UniversityActive in the last 2 years
Wan‐Xin Peng
Matched on ORCID iD 0000-0002-2551-8899; OpenAlex author ID A5060085936. Sources: OpenAlex.
Their work
- Papers
- 12
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 12
- Correction to: Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling. Co-author DOI 10.1038/s41416-025-03208-w↗
- [Corrigendum] Furin promotes epithelial‑mesenchymal transition in pancreatic cancer cells via Hippo‑YAP pathway. Co-author DOI 10.3892/ijo.2025.5797↗
- Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]. Co-author DOI 10.1016/j.gendis.2024.101352↗
- N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis. Co-author DOI 10.1016/j.gendis.2022.02.014↗
- Methyl-CpG-binding protein 2 drives the Furin/TGF-β1/Smad axis to promote epithelial-mesenchymal transition in pancreatic cancer cells. Co-author DOI 10.1038/s41389-020-00258-y↗
- PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. Co-author DOI 10.1111/jcmm.14894↗
- LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription. Co-author DOI 10.1038/s41388-019-0918-z↗
- LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Co-author DOI 10.1016/j.bbadis.2018.03.005↗
- Long non‑coding RNA PVT1 promotes epithelial‑mesenchymal transition via the TGF‑β/Smad pathway in pancreatic cancer cells. Co-author DOI 10.3892/or.2018.6462↗
- Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling. Co-author DOI 10.1038/bjc.2016.397↗
- Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway. Co-author DOI 10.3892/ijo.2017.3896↗
- MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.7507↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aihua Gong · 9 shared papers, 2016–2025 · strength 1.00
- Paper Correction to: Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TG… DOI 10.1038/s41416-025-03208-w↗
- Paper [Corrigendum] Furin promotes epithelial‑mesenchymal transition in pancreatic cancer cells via Hippo‑YAP pathway. DOI 10.3892/ijo.2025.5797↗
- Paper PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. DOI 10.1111/jcmm.14894↗
- Min Xu · 9 shared papers, 2016–2025 · strength 1.00
- Paper Correction to: Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TG… DOI 10.1038/s41416-025-03208-w↗
- Paper [Corrigendum] Furin promotes epithelial‑mesenchymal transition in pancreatic cancer cells via Hippo‑YAP pathway. DOI 10.3892/ijo.2025.5797↗
- Paper PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. DOI 10.1111/jcmm.14894↗
- Yin‐Yuan Mo · 4 shared papers, 2016–2024 · strength 0.62
- Paper Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" … DOI 10.1016/j.gendis.2024.101352↗
- Paper N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis. DOI 10.1016/j.gendis.2022.02.014↗
- Paper LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription. DOI 10.1038/s41388-019-0918-z↗
- Youli Zhang · 6 shared papers, 2016–2025 · strength 0.61
- Paper [Corrigendum] Furin promotes epithelial‑mesenchymal transition in pancreatic cancer cells via Hippo‑YAP pathway. DOI 10.3892/ijo.2025.5797↗
- Paper PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. DOI 10.1111/jcmm.14894↗
- Paper LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. DOI 10.1016/j.bbadis.2018.03.005↗
- Jiahong Jiang · 2 shared papers, 2023–2024 · strength 0.45
- Paper Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" … DOI 10.1016/j.gendis.2024.101352↗
- Paper N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis. DOI 10.1016/j.gendis.2022.02.014↗
- Liu Yang · 2 shared papers, 2019–2023 · strength 0.33
- Lu Ge · 3 shared papers, 2016–2020 · strength 0.24
- Paper PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. DOI 10.1111/jcmm.14894↗
- Paper Long non‑coding RNA PVT1 promotes epithelial‑mesenchymal transition via the TGF‑β/Smad pathway in pancreatic cancer cel… DOI 10.3892/or.2018.6462↗
- Paper MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells. DOI 10.18632/oncotarget.7507↗
- Yang Liu · 1 shared paper, 2024 · strength 0.24
- Huizhi Wang · 1 shared paper, 2020 · strength 0.11
- Huizhi Wang · 1 shared paper, 2020 · strength 0.10
- Yawen Liu · 1 shared paper, 2020 · strength 0.10
- Meiting Zhang · 1 shared paper, 2018 · strength 0.08
- Xingxing Zhang · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.